NYSE:BAX

Baxter International Stock Forecast, Price & News

$84.95
+0.03 (+0.04 %)
(As of 04/12/2021 12:33 PM ET)
Add
Compare
Today's Range
$84.40
Now: $84.95
$85.48
50-Day Range
$76.42
MA: $80.52
$86.03
52-Week Range
$74.79
Now: $84.95
$95.19
Volume47,912 shs
Average Volume2.77 million shs
Market Capitalization$42.91 billion
P/E Ratio48.27
Dividend Yield1.15%
Beta0.65
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. It also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.
Baxter International logo

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP07181310
Phone224-948-2000
Employees50,000
Year Founded1931

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$11.36 billion
Cash Flow$5.27 per share
Book Value$15.50 per share

Profitability

Net Income$1.00 billion

Miscellaneous

Market Cap$42.91 billion
Next Earnings Date4/29/2021 (Confirmed)
OptionableOptionable

Headlines

Is BAX Stock A Buy or Sell?
March 29, 2021 |  finance.yahoo.com
See More Headlines

MarketRank

Overall MarketRank

1.88 out of 5 stars

Medical Sector

96th out of 2,011 stocks

Surgical & Medical Instruments Industry

10th out of 169 stocks

Analyst Opinion: 1.3Community Rank: 2.7Dividend Strength: 2.5Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -
$84.95
+0.03 (+0.04 %)
(As of 04/12/2021 12:33 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BAX News and Ratings via Email

Sign-up to receive the latest news and ratings for BAX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Baxter International (NYSE:BAX) Frequently Asked Questions

Is Baxter International a buy right now?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 6 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Baxter International stock.
View analyst ratings for Baxter International
or view top-rated stocks.

What stocks does MarketBeat like better than Baxter International?

Wall Street analysts have given Baxter International a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Baxter International wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Baxter International's next earnings date?

Baxter International is scheduled to release its next quarterly earnings announcement on Thursday, April 29th 2021.
View our earnings forecast for Baxter International
.

How can I listen to Baxter International's earnings call?

Baxter International will be holding an earnings conference call on Thursday, April 29th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Baxter International's earnings last quarter?

Baxter International Inc. (NYSE:BAX) issued its quarterly earnings data on Wednesday, February, 3rd. The medical instruments supplier reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.76 by $0.04. The medical instruments supplier earned $3.18 billion during the quarter, compared to analyst estimates of $3.10 billion. Baxter International had a trailing twelve-month return on equity of 20.81% and a net margin of 7.90%. Baxter International's revenue for the quarter was up 4.7% compared to the same quarter last year. During the same period last year, the business earned $0.97 EPS.
View Baxter International's earnings history
.

How has Baxter International's stock been impacted by COVID-19 (Coronavirus)?

Baxter International's stock was trading at $77.97 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, BAX stock has increased by 9.1% and is now trading at $85.07.
View which stocks have been most impacted by COVID-19
.

How often does Baxter International pay dividends? What is the dividend yield for Baxter International?

Baxter International announced a quarterly dividend on Tuesday, February 16th. Stockholders of record on Friday, February 26th will be paid a dividend of $0.245 per share on Thursday, April 1st. This represents a $0.98 dividend on an annualized basis and a yield of 1.15%. The ex-dividend date of this dividend is Thursday, February 25th.
View Baxter International's dividend history
.

Is Baxter International a good dividend stock?

Baxter International pays an annual dividend of $0.98 per share and currently has a dividend yield of 1.15%. Baxter International has been increasing its dividend for 5 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio of Baxter International is 29.61%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Baxter International will have a dividend payout ratio of 28.49% next year. This indicates that Baxter International will be able to sustain or increase its dividend.
View Baxter International's dividend history.

What guidance has Baxter International issued on next quarter's earnings?

Baxter International updated its FY21 earnings guidance on Thursday, February, 4th. The company provided earnings per share (EPS) guidance of $3.35-3.43 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.49. The company issued revenue guidance of +7-8% (implying $12.5-12.6 billion), compared to the consensus revenue estimate of $12.17 billion.

What price target have analysts set for BAX?

15 brokers have issued 12 month price objectives for Baxter International's shares. Their forecasts range from $80.00 to $105.00. On average, they expect Baxter International's share price to reach $91.79 in the next year. This suggests a possible upside of 7.9% from the stock's current price.
View analysts' price targets for Baxter International
or view top-rated stocks among Wall Street analysts.

Who are Baxter International's key executives?

Baxter International's management team includes the following people:
  • Mr. Jose E. Almeida, Chairman, Pres & CEO (Age 59, Pay $2.12M) (LinkedIn Profile)
  • Mr. James K. Saccaro, Exec. VP & CFO (Age 48, Pay $835.03k)
  • Mr. Sean B. W. Martin, Sr. VP & Gen. Counsel (Age 58, Pay $1.33M) (LinkedIn Profile)
  • Mr. Giuseppe Accogli, Sr. VP & Pres of Americas (Age 50, Pay $1.52M) (LinkedIn Profile)
  • Mr. Cristiano Franzi, Sr. VP & Pres for EMEA (Age 58, Pay $1.5M) (LinkedIn Profile)
  • Mr. Brian C. Stevens, Sr. VP, Chief Accounting Officer & Controller (Age 46)
  • Dr. Sumant Ramachandra, Pres of Pharmaceuticals and Sr. VP, Chief Science & Technology Officer (Age 52)
  • Mr. Talvis P. Love, Sr. VP & Chief Information Officer
  • Ms. Clare Trachtman, VP of Investor Relations
  • Ms. Stacey Eisen, Sr. VP of Global Communications (LinkedIn Profile)

What is José (Joe) Almeida's approval rating as Baxter International's CEO?

506 employees have rated Baxter International CEO José (Joe) Almeida on Glassdoor.com. José (Joe) Almeida has an approval rating of 85% among Baxter International's employees.

Who are some of Baxter International's key competitors?

What other stocks do shareholders of Baxter International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), Johnson & Johnson (JNJ), Pfizer (PFE), Cisco Systems (CSCO), Honeywell International (HON), Intel (INTC), Abbott Laboratories (ABT), The Procter & Gamble (PG), AT&T (T) and Verizon Communications (VZ).

What is Baxter International's stock symbol?

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Who are Baxter International's major shareholders?

Baxter International's stock is owned by many different institutional and retail investors. Top institutional shareholders include Huntington National Bank (0.12%), Pensionfund DSM Netherlands (0.01%), Trust Co. of Toledo NA OH (0.01%), Stillwater Investment Management LLC (0.00%), Everence Capital Management Inc. (0.00%) and Home Federal Bank of Tennessee (0.00%). Company insiders that own Baxter International stock include Albert P L Stroucken, Andrew Frye, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Sean Martin, Third Point Llc and Thomas T Stallkamp.
View institutional ownership trends for Baxter International
.

Which major investors are selling Baxter International stock?

BAX stock was sold by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co., Trust Co. of Toledo NA OH, Park National Corp OH, M&R Capital Management Inc., Stillwater Investment Management LLC, Carroll Financial Associates Inc., and Private Capital Group LLC. Company insiders that have sold Baxter International company stock in the last year include Albert P L Stroucken, Andrew Frye, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, and John D Forsyth.
View insider buying and selling activity for Baxter International
or view top insider-selling stocks.

Which major investors are buying Baxter International stock?

BAX stock was acquired by a variety of institutional investors in the last quarter, including Everence Capital Management Inc., Huntington National Bank, Pensionfund DSM Netherlands, and Home Federal Bank of Tennessee.
View insider buying and selling activity for Baxter International
or or view top insider-buying stocks.

How do I buy shares of Baxter International?

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Baxter International's stock price today?

One share of BAX stock can currently be purchased for approximately $85.07.

How much money does Baxter International make?

Baxter International has a market capitalization of $42.97 billion and generates $11.36 billion in revenue each year. The medical instruments supplier earns $1.00 billion in net income (profit) each year or $3.31 on an earnings per share basis.

How many employees does Baxter International have?

Baxter International employs 50,000 workers across the globe.

Does Baxter International have any subsidiaries?

The following companies are subsidiares of Baxter International: ApaTech Limited, Baxter (China) Investment Co. Ltd, Baxter (Hellas) EPE, Baxter (India) Private Limited, Baxter AO, Baxter Belgium SPRL, Baxter Company Ltd, Baxter Corporation (Canada), Baxter Corporation Englewood, Baxter Deutschland GmbH, Baxter Distribution Center Europe SA, Baxter Healthcare (Guangzhou) Company Ltd, Baxter Healthcare (Shanghai) Company Ltd., Baxter Healthcare (Suzhou) Company Ltd, Baxter Healthcare (Thailand) Company Limited, Baxter Healthcare (Tianjin) Co. Ltd., Baxter Healthcare Corporation, Baxter Healthcare Limited, Baxter Healthcare Limited (Hong Kong China), Baxter Healthcare Limited (Taiwan), Baxter Healthcare Pty Ltd, Baxter Healthcare SA, Baxter Healthcare SA (Singapore Woodlands Branch), Baxter Healthcare Trading (Shanghai) Co. Ltd., Baxter Holding B.V., Baxter Hospitalar Ltda., Baxter Incorporated, Baxter Innovations & Business Solutions Private Limited (India), Baxter Limited, Baxter Manufacturing (Thailand) Co. Ltd., Baxter Medical AB, Baxter Oncology GmbH, Baxter Pharmaceutical Solutions LLC, Baxter Pharmaceuticals (Asia) Pte Ltd., Baxter Pharmaceuticals India Pvt Ltd., Baxter Polska Sp. z o.o., Baxter Productos Medicos Ltda., Baxter R and D Europe SPRL, Baxter S.A. de C.V., Baxter S.A.S., Baxter S.L., Baxter S.p.A., Baxter SA, Baxter Sales and Distribution LLC, Baxter Services Europe SA, Baxter Shared Services & Competencies Limited, Baxter de Guatemala Sociedad Anonima, Bieffe Medital S.p.A., Cheetah Medical, Cheetah Medical (Israel) Ltd., Cheetah Medical (UK) Limited, Cheetah Medical Inc., Gambro AB, Gambro Dasco S.p.A., Gambro Dialysatoren GmbH, Gambro Industries SAS, Gambro Lundia AB, Gambro Renal Products Inc., Laboratorios Baxter S.A., RTS Colombia SAS, Synovis Life Technologies Inc., and Synovis Micro Companies Alliance Inc..

When was Baxter International founded?

Baxter International was founded in 1931.

What is Baxter International's official website?

The official website for Baxter International is www.baxter.com.

Where are Baxter International's headquarters?

Baxter International is headquartered at One Baxter Parkway DF2-1W, Deerfield IL, 60015.

How can I contact Baxter International?

Baxter International's mailing address is One Baxter Parkway DF2-1W, Deerfield IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]


This page was last updated on 4/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.